This study demonstrates that elevated serum GALP (aOR 1.55) and HMGB1 (aOR 1.65) independently predict GDM development in PCOS pregnancies, with combined biomarker assessment showing superior predictive accuracy (AUC 0.84). Here, HMGB1 is linked to gestational diabetes.